More specifically, the expression of 19 genes (CHMP4C, CYCS, NLRP2, GSDME, CASP9, PLCG1, IL1A, TP63, CHMP2A, PRKACA, HMGB1, BAX, GSDMB, CHMP4A, GPX4, CHMP4B, CHMP7, NLRP1, CASP6) were downregulated while the expression of 28 other genes (CASP3, GSDMA, AIM2, NLRP6, CHMP3, IRF2, TIRAP, SCAF11, PJVK, CASP8, GSDMC, IL6, PYCARD, IL18, GSDMD, NLRC4, IRF1, TP53, TNF, NOD2, CASP5, CASP4, GZMB, CASP1, NLRP3, IL1B, GZMA, ELANE) were upregulated in AML compared with normal samples. The gene discussed is NLRP2; the disease is acute myeloid leukemia.